Losartan and Palpitations

Adverse Event Profile

• Losartan has a notably favorable cardiac tolerability profile compared to many other antihypertensive agents, particularly regarding symptomatic bradycardia or rhythm disturbances, as reported by the American Heart Association 1

Clinical Monitoring

• Monitor serum electrolytes and renal function within 1-2 weeks of initiating losartan, as metabolic disturbances could manifest as palpitations, according to the European Society of Cardiology 2